L’Oreal Picks Up CeraVe Skin Care Via $1.3bn Deal With Valeant

The CeraVe, AcneFree and Ambi skin-care lines will change hands from Valeant Pharmaceuticals to L’Oreal under a deal announced Jan. 10, beefing up the latter’s dermatologist-aligned Active Cosmetics division.